Series B - Codagenix
Investment Firm
Overview
Codagenix develops live-attenuated viral vaccines to provide target antigens placed in an attenuated backbone virus.
Announced Date
Feb 15, 2023
Closed on Date
Feb 15, 2023
Funding Type
Series B
Highlights
Location
New York, United States, North America
Social
Investor Lead
Participant Investors
2
| Investor Name |
|---|
 Serum Institute of India Pvt. Ltd. |
Round Details and Background
Codagenix raised $25000000 on 2023-02-15 in Series B
Codagenix develops live-attenuated viral vaccines to provide target antigens placed in an attenuated backbone virus.
Company Funding History
12
| Announcment Date | Transaction Name | Number Of Investors | Lead Investor | Money Raised |
|---|---|---|---|---|
| Oct 12, 2017 |  Venture Round - Codagenix | 1 | - | 3.0M |
| Jun 12, 2015 | Series A - Codagenix | 1 | - | 2.0M |
| Jun 28, 2014 | Grant - Codagenix | - | 1.2M | |
| Jul 01, 2012 | Grant - Codagenix | - | 600.0K |
Recent Activity
There is no recent news or activity for this profile.